M Ventures participated in a $28m round completed by Plexium, which is working on small molecule drugs to treat cancer or neurodegenerative diseases.

Amgen and Illumina-backed genetic sequencing technology developer Oxford Nanopore is reportedly eyeing a $2.1bn private placement.

Tencent has led a series E-plus round for Taimei as part of a capital influx totalling $212m, with SoftBank's SBCVC unit also among the investors.

Yeshiva University’s Innovation Lab accelerator has more than doubled the number participating in its latest cohort, with a number of AI-driven technologies among those selected.

Oxford Nanopore is reportedly eyeing a $2.1bn private placement that could offer an exit to Woodford Investment Management.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

ArsenalBio has picked up $85m in funding to commercialise immunotherapy engineering research resulting from a collaboration that includes PICI and UCSF.

Intel Capital's Wendell Brooks is among the donors to a philanthropic fund that will invest in early-stage University of Michigan spinouts.

Tigermed has put up $12m for biotech-oriented fund TG Sino-Dragon Fund, which is also backed by Temasek and which has set a $62m target for its final close.